Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells.
Front Immunol
; 11: 1771, 2020.
Article
in En
| MEDLINE
| ID: mdl-32922390
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytotoxicity, Immunologic
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents, Immunological
/
Multiple Myeloma
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
Switzerland